Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 2,672 shares at $9.41 ($25K) on 2023-09-18, disclosed to the SEC on 2023-09-20.
Scheduled sale ($25k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |